BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,143,765 | -18.0% | 5,080,521 | +3.2% | 0.05% | -13.6% |
| Q2 2023 | $311,178,725 | +34.6% | 4,923,714 | -4.2% | 0.06% | +28.3% |
| Q1 2023 | $231,145,257 | +5.4% | 5,137,703 | +2.7% | 0.05% | +4.5% |
| Q4 2022 | $219,200,182 | -13.0% | 5,003,428 | +30.8% | 0.04% | -18.5% |
| Q3 2022 | $251,962,000 | +99.6% | 3,823,979 | +53.0% | 0.05% | +116.0% |
| Q2 2022 | $126,257,000 | -49.4% | 2,499,674 | -36.1% | 0.02% | -41.9% |
| Q1 2022 | $249,703,000 | -33.0% | 3,908,944 | +12.4% | 0.04% | -28.3% |
| Q4 2021 | $372,457,000 | +13.2% | 3,477,325 | +8.7% | 0.06% | +7.1% |
| Q3 2021 | $328,893,000 | +85.5% | 3,199,041 | +58.7% | 0.06% | +86.7% |
| Q2 2021 | $177,333,000 | +36.6% | 2,016,062 | +51.0% | 0.03% | +30.4% |
| Q1 2021 | $129,829,000 | +11.7% | 1,335,277 | +28.8% | 0.02% | +9.5% |
| Q4 2020 | $116,259,000 | +29.1% | 1,036,630 | +6.7% | 0.02% | +10.5% |
| Q3 2020 | $90,074,000 | -14.3% | 971,667 | -27.9% | 0.02% | -17.4% |
| Q2 2020 | $105,136,000 | +19.8% | 1,347,903 | -10.2% | 0.02% | 0.0% |
| Q1 2020 | $87,748,000 | -55.6% | 1,500,462 | -39.2% | 0.02% | -43.9% |
| Q4 2019 | $197,659,000 | +7.7% | 2,467,327 | -1.2% | 0.04% | 0.0% |
| Q3 2019 | $183,532,000 | -29.0% | 2,498,045 | -8.9% | 0.04% | -28.1% |
| Q2 2019 | $258,675,000 | +27.3% | 2,742,241 | +8.1% | 0.06% | +23.9% |
| Q1 2019 | $203,122,000 | +43.2% | 2,537,439 | -3.6% | 0.05% | +27.8% |
| Q4 2018 | $141,883,000 | -38.2% | 2,631,859 | -10.5% | 0.04% | -25.0% |
| Q3 2018 | $229,615,000 | +33.9% | 2,941,517 | +8.9% | 0.05% | +26.3% |
| Q2 2018 | $171,422,000 | -30.1% | 2,700,399 | +0.9% | 0.04% | -32.1% |
| Q1 2018 | $245,403,000 | +31.8% | 2,676,150 | +8.4% | 0.06% | +36.6% |
| Q4 2017 | $186,140,000 | -16.7% | 2,468,375 | -23.0% | 0.04% | -19.6% |
| Q3 2017 | $223,415,000 | +41.8% | 3,206,772 | +3.1% | 0.05% | +37.8% |
| Q2 2017 | $157,567,000 | +3.1% | 3,109,697 | -18.6% | 0.04% | 0.0% |
| Q1 2017 | $152,826,000 | +328.3% | 3,821,584 | +200.4% | 0.04% | +311.1% |
| Q4 2016 | $35,678,000 | +7.0% | 1,271,961 | +13.3% | 0.01% | +12.5% |
| Q3 2016 | $33,329,000 | +43.2% | 1,122,216 | -2.3% | 0.01% | +33.3% |
| Q2 2016 | $23,270,000 | +140.3% | 1,149,078 | +114.2% | 0.01% | +100.0% |
| Q1 2016 | $9,682,000 | -22.3% | 536,416 | +13.4% | 0.00% | 0.0% |
| Q4 2015 | $12,459,000 | -53.9% | 473,001 | -62.6% | 0.00% | -62.5% |
| Q3 2015 | $26,999,000 | -10.1% | 1,265,173 | +10.9% | 0.01% | 0.0% |
| Q2 2015 | $30,034,000 | – | 1,140,878 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |